Pathology of recurrent diseases in kidney allografts: Membranous nephropathy and focal segmental glomerulosclerosis

Current Opinion in Organ Transplantation

Volumn 18, Issue 3, 2013, Pages 313-318

  Kowalewska, Jolanta ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Activated parietal cells; Focal segmental glomerulosclerosis; Membranous nephropathy; Phospholipase A2 receptor; Podocyte urokinase receptor

Indexed keywords

PHOSPHOLIPASE A2 RECEPTOR; UROKINASE RECEPTOR; AUTOANTIBODY;

CELL DAMAGE; DISEASE COURSE; ELECTRON MICROSCOPY; EPITHELIUM CELL; FOCAL GLOMERULOSCLEROSIS; HISTOPATHOLOGY; HUMAN; IMMUNOFLUORESCENCE; KIDNEY ALLOGRAFT; MEMBRANOUS GLOMERULONEPHRITIS; PATHOGENESIS; PODOCYTE; RECURRENT DISEASE; REVIEW; ALLOTRANSPLANTATION; BLOOD; IMMUNOLOGY; KIDNEY TRANSPLANTATION; METABOLISM; PATHOLOGY;

AUTOANTIBODIES; GLOMERULONEPHRITIS, MEMBRANOUS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; KIDNEY TRANSPLANTATION; PODOCYTES; RECEPTORS, PHOSPHOLIPASE A2; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; RECURRENCE; TRANSPLANTATION, HOMOLOGOUS;

MLCS; MLOWN;

EID: 84879972528     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e3283614ab5     Document Type: Review

References (36)

1. Briganti EM, Russ GR, McNeil JJ, et al. Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med 2002; 347:103-109.
2. Hariharan S, Adams MB, Brennan DC, et al. Recurrent and de novo glomerular disease after renal transplantation: a report from Renal Allograft Disease Registry (RADR). Transplantation 1999; 68:635-641.
3. Canaud G, Audard V, Kofman T, et al. Recurrence from primary and secondary glomerulopathy after renal transplant. Transpl Int 2012; 25:812-824.
4. Cosyns JP, Couchoud C, Pouteil-Noble C, et al. Recurrence of membranous nephropathy after renal transplantation: probability, outcome and risk factors. Clin Nephrol 1998; 50:144-153.
5. Dabade TS, Grande JP, Norby SM, et al. Recurrent idiopathic membranous nephropathy after kidney transplantation: a surveillance biopsy study. Am J Transplant 2008; 8:1318-1322.
6. Debiec H, Guigonis V, Mougenot B, et al. Antenatal membranous glomerulonephritis due to antineutral endopeptidase antibodies. N Engl J Med 2002; 346:2053-2060.
7. Beck LH Jr, Bonegio RG, Lambeau G, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 2009; 361:11-21.
8. Debiec H, Martin L, Jouanneau C, et al. Autoantibodies specific for the phospholipase A2 receptor in recurrent and de novo membranous nephropathy. Am J Transplant 2011; 11:2144-2152.
9. Stahl R, Hoxha E, Fechner K. PLA2R autoantibodies and recurrent membranous nephropathy after transplantation. N Engl J Med 2010; 363:496-498.
10. Blosser CD, Ayalon R, Nair R, et al. Very early recurrence of anti-phospholipase A2 receptor-positive membranous nephropathy after transplantation. Am J Transplant 2012; 12:1637-1642.
11. Debiec H, Hanoy M, Francois A, et al. Recurrent membranous nephropathy in an allograft caused by IgG3kappa targeting the PLA2 receptor. J Am Soc Nephrol 2012; 23:1949-1954.
12. Doi T, Mayumi M, Kanatsu K, et al. Distribution of IgG subclasses in membranous nephropathy. Clin Exp Immunol 1984; 58:57-62.
13. Kuroki A, Shibata T, Honda H, et al. Glomerular and serum IgG subclasses in diffuse proliferative lupus nephritis, membranous lupus nephritis, and idiopathic membranous nephropathy. Intern Med 2002; 41:936-942.
14. Noel LH, Aucouturier P, Monteiro RC, et al. Glomerular and serum immunoglobulin G subclasses in membranous nephropathy and antiglomerular basement membrane nephritis. Clin Immunol Immunopathol 1988; 46:186-194.
15. Kearney N, Podolak J, Matsumura L, et al. Patterns of IgG subclass deposits in membranous glomerulonephritis in renal allografts. Transplant Proc 2011; 43:3743-3746.
16. Rodriguez EF, Cosio FG, Nasr SH, et al. The pathology and clinical features of early recurrent membranous glomerulonephritis. Am J Transplant 2012; 12:1029-1038.
17. North American Pediatric Renal Trials and Collaborative Studies. NAPRTS annual report 2011.
18. US Renal Data System. USRDS 2012 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2012.
19. Thomas DB, Franceschini N, Hogan SL, et al. Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants. Kidney Int 2006; 69:920-926.
20. Choy BY, Chan TM, Lai KN. Recurrent glomerulonephritis after kidney transplantation. Am J Transplant 2006; 6:2535-2542.
21. Vinai M, Waber P, Seikaly MG. Recurrence of focal segmental glomerulosclerosis in renal allograft: an in-depth review. PediatrTransplant 2010; 14:314-325.
22. Ponticelli C. Recurrence of focal segmental glomerular sclerosis (FSGS) after renal transplantation. Nephrol Dial Transplant 2010; 25: 25-31.
23. Savin VJ, Sharma R, Sharma M, et al. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 1996; 334:878-883.
24. Wei C, El Hindi S, Li J, et al. Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med 2011; 17:952-960.
25. Wei C, Moller CC, Altintas MM, et al. Modification of kidney barrier function by the urokinase receptor. Nat Med 2008; 14:55-63.
26. D'Agati VD. Podocyte injury in focal segmental glomerulosclerosis: lessons from animal models (a play in five acts). Kidney Int 2008; 73:399-406.
27. Chang JW, Pardo V, Sageshima J, et al. Podocyte foot process effacement in postreperfusion allograft biopsies correlates with early recurrence of proteinuria in focal segmental glomerulosclerosis. Transplantation 2012; 93:1238-1244.
28. Gallon L, Leventhal J, Skaro A, et al. Resolution of recurrent focal segmental glomerulosclerosis after retransplantation. N Engl J Med 2012; 366:1648-1649.
29. Wharram BL, Goyal M, Wiggins JE, et al. Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J Am Soc Nephrol 2005; 16:2941-2952.
30. Shankland SJ. The podocyte's response to injury: role in proteinuria and glomerulosclerosis. Kidney Int 2006; 69:2131-2147.
31. Ronconi E, Sagrinati C, Angelotti ML, et al. Regeneration of glomerular podocytes by human renal progenitors. J Am Soc Nephrol 2009; 20:322-332.
32. Appel D, Kershaw DB, Smeets B, et al. Recruitment of podocytes from glomerular parietal epithelial cells. J Am Soc Nephrol 2009; 20:333-343.
33. Sagrinati C, Netti GS, Mazzinghi B, et al. Isolation and characterization of multipotent progenitor cells from the Bowman's capsule of adult human kidneys. J Am Soc Nephrol 2006; 17:2443-2456.
34. Bourguignon LY, Zhu H, Shao L, Chen YW. CD44 interaction with c-Src kinase promotes cortactin-mediated cytoskeleton function and hyaluronic acid-dependent ovarian tumor cell migration. J Biol Chem 2001; 276: 7327-7336.
35. Smeets B, Angelotti ML, Rizzo P, et al. Renal progenitor cells contribute to hyperplastic lesions of podocytopathies and crescentic glomerulonephritis. J Am Soc Nephrol 2009; 20:2593-2603.
36. Fatima H, Moeller MJ, Smeets B, et al. Parietal epithelial cell activation marker in early recurrence of FSGS in the transplant. Clin J Am Soc Nephrol 2012; 7:1852-1858.